Is Perjeta a chemotherapy drug?
- Perjeta (generic name: pertuzumab) is considered a targeted cancer therapy, which is different from chemotherapy.
- Traditional chemotherapy kills cancer cells that grow and divide rapidly, and may also affect normal cells.
- Targeted drug therapy like Perjeta attacks human epidermal growth factor receptor 2 (HER2) proteins on certain cancer cells that cause rapid growth.
- Normal cells have fewer HER2 proteins, but targeted therapy may affect them, too.
HER2+ breast cancer cells have too many HER2 receptors which can cause cells to grow and divide rapidly. Perjeta targets HER2 receptors to slow down rapid growth. However, fewer amounts of HER2 proteins can be found on healthy cells, too, which may lead to side effects, some of which can be serious.
Perjeta is approved to treat early or metastatic breast cancer and is a member of the HER2 inhibitors drug class. Perjeta is given with another targeted treatment called Herceptin (trastuzumab), which also targets HER2 receptors, but in a different way.
Bottom Line
- Perjeta (pertuzumab) is considered a targeted cancer therapy, which is different from chemotherapy.
- Chemotherapy works by killing rapidly growing cancer cells, but may also affect normal cells.
- Perjeta attacks certain proteins on breast cancer cells that cause rapid growth. However, normal cells also have HER2 proteins (in fewer amounts), so targeted therapy may affect them, too, and possibly cause side effects.
This is not all the information you need to know about Perjeta for safe and effective use. Review the full Perjeta information here, and discuss this information with your doctor or other health care provider.
References
- Perjeta (pertuzumab) Product Information. Genentech. South San Francisco, CA. https://www.gene.com/download/pdf/perjeta_prescribing.pdf
- Perjeta.com. Genentech. Accessed August 28, 2020 at https://www.perjeta.com
Read next
What is TCHP chemotherapy and how is it used?
TCHP is a combination of Taxotere (docetaxel), carboplatin (Paraplatin), Herceptin (trastuzumab), Perjeta (pertuzumab). It is used to treat early-stage HER2-positive breast cancer.
Continue reading
How long can you stay on Herceptin and Perjeta?
If you are receiving Perjeta for treatment of HER2+ early breast cancer, you may continue treatments with Herceptin every 3 weeks for one year (18 cycles total). For the treatment of HER2+ metastatic breast cancer, you will receive Perjeta and Herceptin until the medicine no longer controls your breast cancer or you have side effects that require you to stop treatment. You may receive other treatments with these medications. Continue reading
How much does Perjeta cost?
Perjeta (pertuzumab) intravenous solution (420 mg per 14 milliliters) costs about $5,534 if you are paying cash with a discount, or over $99,000 per year. Your insurance will be billed for this medication if you have coverage. You may have additional costs associated with administration of this medication. If you cannot afford this drug, the manufacturer Genentech may be able to help. Continue reading
See also:
Related medical questions
- What common side effects occur with Perjeta?
- How long do Perjeta infusions last?
- How do Herceptin (trastuzumab) and Perjeta (pertuzumab) work together?
- What is the strongest chemotherapy drug for breast cancer?
- Why are my nipples sore? 7 possible causes
- How long do letrozole side effects last?
- What happens when you stop taking letrozole?
- What is the success rate of Keytruda?
- Does anastrozole cause hair loss?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- How long does Ibrance extend life?
- Is letrozole a form of chemotherapy?
- What does anastrozole do to your body?
- What are Monoclonal Antibodies and how do they work?
- How well does Enhertu work in metastatic breast cancer?
- What is the lifetime or cumulative dose for Adriamycin?
- Does Femara make your hair fall out?
- Why give Taxol (Paxel) before carboplatin?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- What is the TC chemo regimen and how does it treat breast cancer?
- Does letrozole affect blood sugar levels?
- How does Adriamycin and Cytoxan (AC chemo) work for Breast Cancer?
- What is the success rate for Femara in breast cancer?
- Will insurance pay for the cost of Ibrance?
- Treatments for Menopause
- What are 10 key Ibrance side effects to watch out for?
- What are the long-term side effects of Adriamycin?
- Why do you need to take Xeloda with food?
- Is it common to lose hair AFTER stopping tamoxifen?
- Which is better - Aromasin or Femara?
Drug information
Related support groups
- Perjeta (8 questions, 6 members)
- Pertuzumab (4 questions, 4 members)
- Breast Cancer (132 questions, 311 members)
- Breast Cancer, Metastatic (58 questions, 80 members)